Silibinin leads to decreased inflammation arising from dementia and non-dementia diseases, stress, memory impairments, and oxidative damage via inhibition of NF-κB signaling pathway and affecting Akt/mTOR signaling pathway and improves cognition functions (Hwang and Kim, 2011 ▶). Here, NFKB1 is linked to memory impairment.